N/A
This week, Brazil's National Health Surveillance Agency (ANVISA) published proposed monograph changes (including some MRL revisions) for chlorfluazuron, spinetoram, cyproconazole, clethodim, azadirachtin, amicarbazone, azoxystrobin (Consulta Pública n° 296 and n° 306), halosulfuron-methyl, indaziflam, linuron, mepiquat chloride, propaquizafop, triclopyr, thiodicarb, tebuconazole (Consulta Pública n° 304 and n° 308), iodosulfuron-methyl-sodium (links in Portuguese).
Comments on these proposals must be submitted by March 11, 2017 for iodosulfuron-methyl-sodium, azoxystrobin (n° 306), and tebuconazole (n° 308) and by March 10, 2017 for all other active ingredients. Relevant proposed MRLs will display in the Global MRL Database on February 11, 2017.